Jakob Dynnes Hansen is a portfolio Chief Financial Officer specializing in the life sciences industry. A graduate of INSEAD and the University of Copenhagen, he provides strategic financial leadership to several biotech firms simultaneously, including Antag Therapeutics, guiding them through critical growth phases.
He is deeply engaged with the Danish life science ecosystem, with a professional interest in major regional players like Novo Nordisk and developments from his alma mater, the University of Copenhagen.
His career is structured around a unique portfolio model, serving as the strategic CFO for multiple biotech ventures at once.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.